Signed in as:
filler@godaddy.com
Technical Team Expertise
Claire Thompson, Founder and CEO
Background
Multi-award winning scientist, entrepreneur and philanthropist.
Pfizer, GlaxoSmithKline, Molecular Profiles, Oxford PharmaScience
NED, advisory and board roles and multiples SMEs, funding bodies and not for profit organisations.
Entrepreneur in Residence, University of Cambridge.
Honorary Professor, University of Nottingham.
Expertise
Formulation: Solutions, suspensions, injectables, capsules, orally disintegrating tablets, lozenges subcutaneous, ocular, inhaled, and intranasal.
Analytical: XRPD, DSC, TGA, DVS, IR, Raman, microscopy, particle counters, and particle sizers.
Development stages: Preclinical to commercial, patent litigation, lifecycle management, in-licensing technologies, nutraceuticals, and food supplements.
Ali Parry, Chief Scientific Officer
Background
BCM Specials, Brunel Healthcare, BCM Analytical Services, Molecular Profiles, Archimedes, Boots Healthcare International/Reckitt Benckiser, Sanofi
Expertise
Formulation: Solutions, suspensions, injectables, solid oral dosage forms, and ocular.
Analytical: Development and validation of analytical procedures including: HPLC, GC, IC, dissolution, Karl Fischer titrators, UV-VIS spectrophotometers, particle counters, and particle sizers.
Quality and Regulatory: QC and QA management, CAPA and change control management, Validation Master Plan management, IMPD/IND authoring.
Development stages: Preclinical to commercial, patent litigation, lifecycle management, unlicensing medicines, and food supplements.
Solitek brings a new concept in solid state development services for the pharmaceutical, agrochemical and fine chemical industries.
Inaphaea BioLabs is a new Nottingham pharmaceutical services company, based in MediCity (UK), offering cell-based assays specialising in oncology and women’s health.
Their aim is to improve the translation of early drug discovery projects towards the clinic. Driven by a desire to generate deeper biological understanding of drug candidates in discovery and preclinical phases of development, Inaphaea will provide testing services that generate the necessary data, analysis and insights to aid decision making in translational drug development.